[New progress in the development of malignant lymphoma targeting drugs].
Harbin Institute of Hematology & Oncology, Harbin 150010, China.
Jun
J
Ma
D016503:Drug Delivery Systems; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*